Bringing the Oncology Community Together
Login
|
Register
HOME
BONE METS
BREAST
GI CANCER
GU CANCER
HEAD & NECK
HEM-ONC
LUNG
SKIN
PROSTATE
PATHWAYS
NURSES
HENNESSY'S HIGHLIGHTS
PATIENTS
SUPPORTIVE CARE
WOMEN'S CANCER
iPUBS
MEETINGS
ONCLIVE TV
BLOGS
PUBLICATIONS
FDA Approves Axitinib for Advanced Kidney Cancer Patients
Bortezomib Approved for Subcutaneous Injection
Rituximab for Chronic Lymphocytic Leukemia in Treatment-Naïve and Treatment-Experienced Patients
Basis for Secondary Skin Cancers in Patients Taking Vemurafenib Discovered
Breaking News
FDA Approves Axitinib for Advanced Kidney Cancer Patients
The FDA has approved axitinib for the treatment of patients with advanced RCC who have failed to respond to another drug.
Feature
Bortezomib Approved for Subcutaneous Injection
The FDA has deemed subcutaneous injection as a safe and valid method of delivering the drug bortezomib in patients with multiple myeloma.
Feature
Rituximab for Chronic Lymphocytic Leukemia in Treatment-Naïve and Treatment-Experienced Patients
Research
Basis for Secondary Skin Cancers in Patients Taking Vemurafenib Discovered
The molecular basis behind the relatively high incidence of secondary skin cancers after patients received vemurafenib has been discovered.
OncLive TV - A Network of Your Peers
Dr. Fox Discusses Genomic Testing in Breast Cancer
Dr. Hamlin on Brentuximab Vedotin Pharmacology
Dr. Zimran Discusses Gaucher Disease Biomarkers
Dr. Weinreb on the Different Roles in a Gaucher Diagnosis
>>>
Click here for more videos
Latest Oncology Headlines
FDA Approves Axitinib for Advanced Kidney Cancer Patients
The FDA approved axitinib for the treatment of patients with advanced RCC who have failed to respond to another drug.
>
Web Exclusives
Oncology Nurse Perspectives on Developments in Cancer Care
Nurses provide their unique perspectives on many of the recent clinical trials and developments in cancer research.
Onc Nurse
> Feature Story
Oral HPV Infections More Prevalent in Men
Approximately 7% of Americans carry the human papillomavirus (HPV) in their oral cavities, and men are 3 times more likely to carry the virus than women.
>
Web Exclusives
>>>
Click here for more articles
Oncology Resources
A Network of Your Peers
Dr. Baselga Discusses the CLEOPATRA Pertuzumab Trial
Dr. Feldman Discusses the Difficulties of Rare Lymphomas
Dr. Berenson Discusses the Carfilzomib Toxicity Profile
Dr. Diehl Discusses Brentuximab Vedotin
>>>
View More on OncLive TV
Editors' Corner
Andrew Pecora, MD
Oncology & Biotech News
The FDA Revokes
Maurie Markman, MD
OncologyLive
CYP2D6 Breast Cancer Debate Shows Intricacies of Genotyping
Andre Goy, MD, MS
Contemporary Oncology
Progress Made, but More Work Lies Ahead in CLL and CRC Treatment
Lisa Schulmeister, RN, OCN
OncNurse
Electronic Cigarettes
>>>
View the entire advisory board
Oncology Connection
Intellipoll
How many different journals do you receive?
Tuesday, August 23rd, 2011
How many different journals do you receive?
>7
5-7
3-5
1-3
None
How many conferences do you attend each year?
Tuesday, August 23rd, 2011
How many conferences do you attend each year?
None
1-3
3-5
5-7
>7
Has a reimbursement issue negatively affected your practice?
Tuesday, August 23rd, 2011
Has a reimbursement issue negatively affected your practice?
Yes
No
Is the Advancement of Speech Recognition Technology Good for Medical Facilities?
Monday, April 18th, 2011
Is the Advancement of Speech Recognition Technology Good for Medical Facilities?
Yes
No
Not Sure
Will you attend an oncology conference this year?
Tuesday, March 29th, 2011
Will you attend an oncology conference this year?
Yes
No
Not Sure
Has the Affordable Care Act hurt your oncology practice?
Tuesday, March 29th, 2011
Has the Affordable Care Act hurt your oncology practice?
Yes
No
Has the Affordable Care Act helped cancer patients?
Tuesday, March 29th, 2011
Has the Affordable Care Act helped cancer patients?
Yes
No
Has your practice fully implemented electronic medical records?
Tuesday, March 29th, 2011
Has your practice fully implemented electronic medical records?
Yes
No
Partially
Do you think Avastin should remain approved for women with breast cancer?
Monday, March 28th, 2011
Do you think Avastin should remain approved for women with breast cancer?
Yes
No
Not Sure
No Iframes
Important Oncology Websites
Cancer Centers
Advocacy Groups
Associations
Arizona Cancer Center
Mayo Clinic
Case Comprehensive Cancer Center
Dana-Farber/Harvard Cancer Center
Duke Cancer Institute
Fox Chase Cancer Center
Holden Comprehensive Cancer Center
John Theurer Cancer Center
Jonsson Comprehensive Cancer Center
Kimmel Cancer Center at Jefferson University Hospital
MD Anderson Cancer Center
Memorial Sloan-Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
UAB Comprehensive Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center
University of Chicago Comprehensive Cancer Center
University of Michigan Comprehensive Cancer Center
AACR: Survivors and Advocates
American Cancer Society
Bladder Cancer Advocacy Network
Breast Cancer Alliance
Cancer and Careers
Cancer Support Community
Cancer Treatment Centers of America
Caring4Cancer
Children's Brain Tumor Foundation
Lung Cancer Alliance
Lung Cancer Online
Malecare
MyLifeLine.org
National Breast Cancer Coalition
National Breast Cancer Foundation, Inc.
National Coalition for Cancer Survivorship
Prostate Cancer Support
Us TOO
Women Against Prostate Cancer
American Association for Cancer Research
American Brain Tumor Association
American Childhood Cancer Organization
American Joint Committee on Cancer
American Lung Association
American Society for Clinical Oncology
American Society of Hematology
Cancer Treatment Resource
Children's Cancer Association
Kidney Cancer Association
Leukemia and Lymphoma Society
Lymphoma Information
Lymphoma Research Foundation
National Alliance of Breast Cancer Organizations
National Brain Tumor Society
National Cancer Institute
Thyroid Cancer Survivor's Association
Oncology Publications
No 0
HOME
BONE METS
BREAST
GI CANCER
GU CANCER
HEAD & NECK
HEM-ONC
LUNG
SKIN
PROSTATE
PATHWAYS
NURSES
HENNESSY'S HIGHLIGHTS
PATIENTS
SUPPORTIVE CARE
WOMEN'S CANCER
iPUBS
MEETINGS
ONCLIVE TV
BLOGS
PUBLICATIONS
About Us
|
Advertise
|
Advisory Board
|
Archives
|
Contact Us
|
Forgot Password
American Journal of Managed Care
American Journal of Pharmacy Benefits
HCPLive
OncLive
PainLive
Pharmacy Times
Physician's Money Digest
Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Patient Resources
Specialties
Web Exclusives
About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright OncLive 2006-2012
Intellisphere, LLC. All Rights Reserved.